• The PLR/NLR correlate with CRP and ESR as well as disease classed as active using the Kerr criteria. However the correlations are quite weak (r < 0.3) so they only explain about one-third of the observed linkage. Similarly, the ROC curves have values <0.7 for both and the predictive cut-off points thus derived have low sensitivity.
• The PLR/NLR are in essence non-specific markers like the acute phase response. This is the first time they have been applied to the study of TA but altered ratios have previously been described across acute and chronic rheumatic diseases (acute gout through to chronic RA, AS, Sjogrens, etc) . This begs the question of whether these ratios are telling us any more than the CRP does -and the authors need to establish whether this is the case. For example, it could be useful to see a ROC curve for CRP to compare with those for NLR.
• The PLR/NLR have also been used as prognostic markers for survival in a range of cancers together with atherosclerosis, liver disease, diabetes and morbid obesity. This raises doubts about the specificity of the test when applied to a single disease entity. It will need a prospective study (as the authors acknowledge) to inform us whether a changed ratio will predict flares of TA rather than the existence of a common co-morbidity such as infection or diabetes. Thus the abstract is incorrect to state that this retrospective study is aimed to evaluate the predictive value of PLR/NLR. It can only evaluate the associations.
• There must also be doubt in this cross-sectional study as to what pathology an altered ratio reflects in an individual patient. Currently there is no overt link between altered circulating inflammatory cell ratios and the immunopathology of lesions in the blood vessels of patients with TA.
• It is a pity that the study used the Kerr criteria, an arbitrarily-derived activity score that has never been validated. The more recent ITAS score is much more comprehensive, is scalable, and has been validated. Using that would have had the added advantage of providing a larger data-base to examine which individual factors in TA are reflected by an altered PLR/NLR.
• There is a danger of a circular argument when a test that correlates with the acute phase is applied to distinguish active disease as defined by the Kerr criteria, since CRP/ESR is used in that definition of disease activity. There may well be more benefit from examining the whole TA data set in an open-minded approach to determine which of the individual Kerr criteria are present in those cases with ratios that are outside the normal range.
• The results presented show a considerable overlap in the PLR/NLR between TA cases labelled as active or inactive. Does this suggest a continuing disease process in those patients with inactive disease by the Kerr criteria? This would be unsurprising in the light of the major problem over-hanging the whole field -that of defining what is meant by disease activity in TA. Some patients show systemic symptoms such as fever and weight loss -but much less frequently than they are seen in small or medium vessel vasculitis. Some have elevated acute phase reactants but the levels are lower than seen in giant cell/temporal arteritis. These factors even when present have not been closely linked to disease progression in the form of vascular stenosis. Patients not infrequently present with a vessel blockage but give no history of preceding illness despite extensive vascular stenosis on imaging. The concept of a form of progressive vessel wall inflammation that can proceed to fibrosis even in the absence of clinical signs is supported by the finding of positive inflammatory or immune cell infiltrates on biopsies obtained at vascular surgery from apparently inactive patients. The authors have too easily accepted that the un-validated Kerr criteria define the pathological state of TA. Examining the correlations between new tests such as the circulating blood cell ratios with a range of clinical features, without pre-labelling the patients as "inflammatory", has the potential to provide new insights into which aspect of disease activity is being observed. Carrying that unbiased approach into longitudinal studies could allow us in due course to look back to determine which features truly predicted progressive clinical disease.
• In conclusion, the current study provides further evidence of classic inflammation in TA patients with clinical and/or laboratory evidence that this is occurring. It is not clear whether this is also evidence for the sub-clinical process that can produce progressive vessel wall fibrosis locally. Only future longitudinal studies will tell whether these tests can predict outcome in terms of progressive stenotic events. In view of the ease of calculating these ratios from readily available data. It is to be hoped that the authors (and other centres) will carry out such studies widely.
VERSION 1 -AUTHOR RESPONSE
Reviewer: 1 Reviewer Name: Yanwen Qin Institution and Country: The Key Laboratory of Remodeling-related Cardiovascular Diseases, Ministry of Education, Beijing Collaborative Innovation Centre for Cardiovascular Disorders, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing 100029, China; Please state any competing interests or state "None declared": None declared Please leave your comments for the authors below The association between Platelet-to-lymphocyte ratio (PLR) and Neutrophil-to-lymphocyte ratio (NLR) and some autoimmune diseases are well known. In this study, Dr. Pan and associates showed that the PLR and NLR could be as predictors to monitor the inflammatory response and disease activity in TAK patients. This is an interesting observation. However, some questions should be clear:
1. The number of samples is relatively small. Response： Takayasu's arteritis (TAK) is a rare disease, TAK is far less common with reported worldwide incidence rates of only 1-2 per million. In Europe and North America, the estimated prevalence is 200 per 100 000 and the incidence is 20-30 per 100 000 [1] . the prevalence is more than 0.004% in Japan [2] . Patients of TAK less than 100 people per year visited in our hospital. 2. Given the medication such as steroids or immunosuppressive agents can change the numbers of blood cells, it is unclear from the manuscript whether the blood samples were taken prior to medication, especially immunosuppressive agent. Response： Because of some drugs can lead to changes of blood cells, such as steroids may lead to increase in white blood cell counts and neutrophil counts. All of the patients had glucocorticoid withdrawal for at least 6 months or were newly diagnosed without treatment. Side effects of some immunosuppressive agents (Methotrexate, Cyclophosphamide, Mycophenolate mofetiland Tocilizumab, etc.) may lead to reduction in white blood cells, in this study, patients with drug -related hypoleucocytosis were excluded. For more details, please see "methods" section of manuscript (please see page 3, line 15-17).
3. The writing quality of the paper should be improved, please check gramma and sentences structure. Response： We have carefully checked the spelling and grammar errors, and improved the writing of the article. Reviewer: 2 Reviewer Name: HanerDireskeneli Institution and Country: Marmara University, School of Medicine, Istanbul, Turkey Please state any competing interests or state "None declared": None declared Please leave your comments for the authors below The study by Pan et al. investigates the role of platelet-to-lymphocyte (PLR) and neutrophil-tolymphocyte ratio"s (NLR) in the assessment of Takayasu"s arteritis (TAK). 1. ESR and CRP are traditionally used as biomarkers for the assessment of activity in TAK. PLR and NLR have both moderate sensitivity (37.8-75.6%) and specificity (93.0%-55.8%) when Kerr Criteria is used as the gold standard in this study. To understand whether they perform better than ESR and CRP, ROC curves of these traditional parameters should also be added to the manuscript. Response: Currently, there were no specific serum markers for the diagnosis of TAK and no index that international recommended evaluating the disease activity of TAK. ESR and CRP are traditionally used as biomarkers for the assessment of activity in TAK. In our study, PLR and NLR have both moderate sensitivity (37.8-75.6%) and specificity (93.0%-55.8%) when Kerr Criteria is used as the gold standard, and we also analyzed the relationship between PLR/NLR and disease activity index such as Kerr Criteria, ESR and CRP. Our results showed a positive correlation between the PLR with CRP or ESR, the NLR with Kerr Criteria or CRP also have a strong correlation. This is evidence that supported the PLR and NLR related to TAK disease activity. For the current study, use of Kerr Criteria as the gold standard to draw the ROC curve is not comprehensive, thank you so much for your good suggestion and we have performed ROC curves use traditional parameters ESR and CRP, the results showed that when CRP was used as the gold standard, specificity of NLR was higher than use of Kerr Criteria and ESR; using CRP or ESR as the gold standard, the area under the curve of PLR was higher than that of Kerr Criteria, which further confirmed the relationship between activity PLR/NLR and TAK disease activity, and we have added them to the manuscript and 2. Kerr Criteria requiries the positivity of at least 2 of its 4 items to be accepted as active. But one criteria (only imaging etc) is sometimes also accepted to be sufficient for activity/treatment decisions of the physicians. A second analysis should be done analyzing patient data in three groups (minumum 2 criteria+ vs one criteria vs none). Response： Kerr Criteria is the most widely used standard for evaluation of TAK disease activity. In our study， there were 45 patients who meet 1 criteria (inactive TAK group, most of which only with the radiological or ultrasound change),and 43 patients meet at least 2 criteria (active group), so we divided these patients into 2 groups. A part of the patients only presented radiological or ultrasound changes without clinical or serological abnormal, we will pay more attention to these patients to find new and specific markers associated with radiographic or ultrasound changes in our future research.
Reviewer: 3 Reviewer Name: Paul Bacon Institution and Country: Rheumatology Research Group, Division of Immunity and Infection, College of Medicine and Dentistry, University of Birmingham, Birmingham UK Please state any competing interests or state "None declared": None declared Please leave your comments for the authors below This study sets out to look for new markers of disease activity in Takayasu arteritis (TA). This is an important area since activity is hard to assess clinically in TA, there are no disease-specific markers and the acute phase response measured by ESR/CRP is often unhelpful. The authors use the ratios of circulating cells, data readily available from routine blood counts without expensive new tests, and apply this to a significant cohort of patients of this uncommon disease. Thus the study was well-worth doing -but it remains unclear what the results really signify.
•The PLR/NLR correlate with CRP and ESR as well as disease classed as active using the Kerr criteria. However the correlations are quite weak (r < 0.3) so they only explain about one-third of the observed linkage. Similarly, the ROC curves have values <0.7 for both and the predictive cut-off points thus derived have low sensitivity. Response: There were no specific serum markers for diagnosis of TAK and no international recommendation to evaluate the disease activity of TAK. ESR and CRP are traditionally biomarkers for the assessment of activity in TAK. In our study, we also analyzed the relationship between PLR/NLR and Kerr Criteria, ESR and CRP, and showed positive correlations between PLR with CRP or ESR, the NLR with Kerr Criteria or CRP also have a strong correlation. This is evidence that supported the PLR and NLR related to TAK disease activity.
• The PLR/NLR are in essence non-specific markers like the acute phase response. This is the first time they have been applied to the study of TA but altered ratios have previously been described across acute and chronic rheumatic diseases (acute gout through to chronic RA, AS, Sjogrens, etc). This begs the question of whether these ratios are telling us any more than the CRP does -and the authors need to establish whether this is the case. For example, it could be useful to see a ROC curve for CRP to compare with those for NLR. Response: Studies have shown that PLR/NLR is associated with a variety of autoimmune diseases. In current study, use of Kerr Criteria as the gold standard to draw the ROC curve may not comprehensive, thank you for your good suggestion and we have performed ROC curves of traditional parameters ESR or CRP, the results showed that when CRP was used as the gold standard, specificity of NLR was higher than use of Kerr Criteria or ESR; using CRP and ESR as the gold standard, the area under the curve of PLR was larger than that of Kerr Criteria, which further confirmed the relationship between activity PLR/NLR and TAK disease activity, and we have added them to the manuscript and Figures (please see page 5 and 6, and Figure 2 -4).
• The PLR/NLR have also been used as prognostic markers for survival in a range of cancers together with atherosclerosis, liver disease, diabetes and morbid obesity. This raises doubts about the specificity of the test when applied to a single disease entity. It will need a prospective study (as the authors acknowledge) to inform us whether a changed ratio will predict flares of TA rather than the existence of a common co-morbidity such as infection or diabetes. Thus the abstract is incorrect to state that this retrospective study is aimed to evaluate the predictive value of PLR/NLR. It can only evaluate the associations. Response: Some studies have reveals the relationship between PLR and NLR and cancers, cardiovascular diseases and other autoimmune disease. In order to avoid the interference with the results, in this study, patients who had chronic or current infections, tumors, hematologic diseases, other autoimmune diseases, lymphoproliferative disorders, hepatosplenic diseases or a history of allergic diseases were excluded (please see page 3, line 17-20 ). We agree with the reviewer's opinion, this study is retrospective cross-sectional study, we analyze the relationships of PLR/NLR and TAK disease activity index such as Kerr Criteria, CRP and ESR, instead of predictive value of PLR/NLR. However, prospective studies of the predictive value of the disease activity using NLR/PLR need to perform in future research. And we modified the incorrect state in the abstract (please see page 1).
• There must also be doubt in this cross-sectional study as to what pathology an altered ratio reflects in an individual patient. Currently there is no overt link between altered circulating inflammatory cell ratios and the immunopathology of lesions in the blood vessels of patients with TA. Response: There are a considerable number of TAK patients without clinical manifestation or CRP/ESR abnormal, these patients were easy to consider as inactive disease. Because the TAK is mainly involving the aorta and main branches, it is very difficult to obtain pathological specimens. Nevertheless, reviewer provided a very good suggestion, we will cooperate with cardiovascular surgeon in the future, to obtain more direct evidence.
• It is a pity that the study used the Kerr criteria, an arbitrarily-derived activity score that has never been validated. The more recent ITAS score is much more comprehensive, is scalable, and has been validated. Using that would have had the added advantage of providing a larger data-base to examine which individual factors in TA are reflected by an altered PLR/NLR. Response: Kerr Criteria include 4 aspects for assessment of disease activity of TAK: symptoms, signs, ESR and imaging findings, as reviewers mentioned, Kerr Criteria is not a comprehensive standard to reflect disease activity. Therefore, we also evaluated the correlation between the traditional disease activity indexes CRP or ESR and NLR /PLR, also confirmed the correlation between NLR /PLR and ESR or CRP. In recent years the ITAS score is more comprehensive and system method to evaluated TAK disease activity, even not yet widely used. Thanks to reviewer for this good suggestion and we will use the ITAS in the future research to evaluate the disease activity of TAK, and we will expand the sample size and test the application value of PLR/NLR in our future research.
• There is a danger of a circular argument when a test that correlates with the acute phase is applied to distinguish active disease as defined by the Kerr criteria, since CRP/ESR is used in that definition of disease activity. Response: There are currently no international guidelines and recommendations for the assessment of TAK disease activity, ESR and CRP are widely used to assess TAK disease activity. In our study, we retrospectively analyzed the relationship between PLR/NLR and disease activity indexes such as Kerr Criteria, ESR and CRP, results showed a positive correlation between the PLR/NLR with CRP or ESR, the NLR with Kerr Criteria or CRP also have positive correlations (please see page 5).
• There may well be more benefit from examining the whole TA data set in an open-minded approach to determine which of the individual Kerr criteria are present in those cases with ratios that are outside the normal range. Response: We use Kerr Criteria as the gold standard to get the cutoff value of PLR/ NLR and examining the whole TA data ,we find 85% of patients with active TAK show abnormal PLR (>183.39) and 72.3% of patients with active TAK show abnormal NLR (>2.417). Maybe, the cutoff values of NLR/PLR calculated by use Kerr Criteria can reflect disease activity in most patients (please see the table below ) (this data not add to the manuscript ).
